No black box warning on record for Spevigo

As of the latest FDA labeling reviewed, Spevigo (SPESOLIMAB-SBZO) does not carry a black box warning. Standard warnings and precautions still apply — see the full Spevigo medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infections: SPEVIGO may increase the risk of infections. Treatment with SPEVIGO is not recommended during any clinically important active infection. Instruct patients to seek medical advice if signs or symptoms of clinically important infection occur during or after treatment. If a clinically important active infection develops, discontinue SPEVIGO until the infection re

No black box warning on record for Spevigo

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Infections: SPEVIGO may increase the risk of infections. Treatment with SPEVIGO is not recommended during any clinically important active infection. Instruct patients to seek medical advice if signs or symptoms of clinically important infection occur during or after treatment. If a clinically important active infection develops, discontinue SPEVIGO until the infection re

Spevigo Black Box Warning

No black box warning on record for Spevigo

Other warnings & precautions

Spevigo Black Box Warning

No black box warning on record for Spevigo

Other warnings & precautions